Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders

International Ophthalmology

Volumn 27, Issue 1, 2007, Pages 11-22

  Abu El Asrar, Ahmed M ^a,d   Van den Steen, Philippe E ^b   Al Amro, Saleh A ^a   Missotten, Luc ^c   Opdenakker, Ghislain ^b   Geboes, Karel ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

CD105; Connective tissue growth factor; Diabetic retinopathy; Gelatinase B; Proliferative vitreoretinopathy

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOGENIC FACTOR; CD34 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; ENDOGLIN; GELATINASE B;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPIRETINAL MEMBRANE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MYOFIBROBLAST; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA BLOOD VESSEL; RETINA GANGLION CELL; RETINA NEOVASCULARIZATION; VITREORETINOPATHY; ZYMOGRAPHY;

ACTINS; ADULT; AGED; ANTIGENS, CD; BLOOD VESSELS; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; EPIRETINAL MEMBRANE; FEMALE; FIBROBLASTS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MATRIX METALLOPROTEINASE 9; MICROGLIA; MIDDLE AGED; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, CELL SURFACE; RETINA; RETINAL GANGLION CELLS; TISSUE DISTRIBUTION;

EID: 34247633082     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9053-x     Document Type: Article

References (42)

1. Blom IE, Goldschmeding R, Leask A (2002) Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol 21:473-482
2. Twigg SM, Joly AH, Chen MM, Tsubaki J, Kim H-S, Hwa V et al (2002) Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 143:1260-1269
3. Wang JF, Olson ME, Ball DK, Brigstock DR, Hart DA (2003) Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Rep Reg 11:220-229
4. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T et al (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126:137-145
5. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: Evidence and potential applications. FASEB J 17:984-992
6. Nguyen M, Arkell J, Jackson CJ (2001) Human endothelial gelatinase and angiogenesis. Int J Biochem Cell Biol 33:960-970
7. Matrisian L (1990) Matrix metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125
8. Paemen L, Martens E, Masure S, Opdenakker G (1995) Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. Eur J Biochem 234:759-765
9. Pagenstecher A, Stalder AK, Kincaid CL, Volk B, Campbell IL (2000) Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. Am J Pathol 157:197-210
10. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z et al (1999) Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464-8475
11. Miller JW, Adamis AP, Aiello P (1997) Vascular endothelial growth factor in ocular neovascularization and proliferative retinopathy. Diabetes Metab Rev 13:37-50
12. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J et al (2000) Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11:25-38
13. Twigg SM, Cao Z, McLennan SV, Burns WC, Brammar G, Forbes JM et al (2002) Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143:4907-4915
14. Zhou G, Li C, Cai L (2004) Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor (-independent pathway. Am J Pathol 165:2033-2043
15. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ et al (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861
16. Tikellis C, Cooper ME, Twigg SM, Burns WC, Tolcos M (2004) Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition. Endocrinology 145:860-866
17. Kuiper EJ, Witmer AN, Klaassen I, Oliver N, Goldschmeding R, Schlingemann RO (2004) Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br J Ophthalmol 88:1082-1087
18. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M et al (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-733
19. Rachfal AW, Brigstock DR (2003) Connective tissue growth factor (CTGF/ CCN2) in hepatic fibrosis. Hepatol Res 26:1-9
20. Meyer P, Wunderlich K, Klain HL, Prünte C, Flammer J (2002) Human connective tissue growth factor mRNA expression of epiretinal and subretinal fibrovascular membranes: A report of three cases. Ophthalmologica 21:284-291
21. Hinton DR, He S, Jin ML, Barron E, Ryan SJ (2002) Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16:422-428
22. He S, Jin ML, Worpel V, Hinton DR (2003) A role of connective tissue growth factor in the pathogenesis of choroidal neovascularization. Arch Ophthalmol 121:1283-1288
23. Hinton DR, Spee C, He S, Wetz S, Usinger W, LaBree L et al (2004) Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care 27:758-764
24. Kuiper EJ, de Smet MD, van Meurs JC, Tan HS, Tanck MWT, Oliver N et al (2006) Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch Ophthalmol 124:1457-1462
25. Park SK, Kim J, Seomun Y, Choi J, Kim DH, Han IO et al (2001) Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun 284:966-971
26. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T et al (2002) Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769-776
27. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP et al (2000) Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Fit1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells. J Biol Chem 275:40725-40731
28. Torsney E, Charton R, Parums D, Collis M, Arthur HM (2002) Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 51:464-470
29. Dales JP, Garcia S, Bonnier P, Duffaud F, Andrac-Meyer L, Ramuz O et al (2003) CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlation between immunohistochemical analysis and long-term follow-up in a series of 929 patients. Am J Clin Pathol 119:374-380
30. Saad RS, Liu YL, Nathan G, Gelebrezze J, Medich D, Silverman JF (2004) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17:197-203
31. Gillard JA, Reed MW, Buttle D, Cross SS, Brown NJ (2004) Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing. Wound Repair Regen 12:295-304
32. Ramos C, Montão M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M et al (2001) Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 24:591-598
33. Majka S, McGuire PG, Das A (2002) Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci 43:260-266
34. Behzadian MA, Wang X-L, Windsor LJ, Ghaly N, Caldwell RB (2001) TGF-β increases retinal endothelial cell permeability by increasing MMP-9: Possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci 42:853-859
35. Das A, Fanslow W, Cerretti D, Warren E, Talarico N, McGuire P (2003) Angiopoietin/Tek interactions regulate MMP-9 expression and retinal neovascularization. Lab Invest 83:1637-1645
36. Giebel SJ, Menicucci G, McGuire PG, Das A (2005) Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85:597-607
37. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160:673-680
38. Das A, McGuire PG, Eriqat C, Ober RR, De Juan E Jr, Williams GA et al (1999) Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 40:809-813
39. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y et al (2003) Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 44:2163-2170
40. Abu El-Asrar AM, Dralands L, Veckeneer M, Geboes K, Missotten L, Van Aelst I et al (1998) Gelatinase B in proliferative vitreoretinal disorders. Am J Ophthalmol 125:844-851
41. Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS (2004) Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: Potential role in capillary branching. Circ Res 94:262-268
42. Das A, McLamore A, Song W, McGuire P (1999) Retinal neovascularization is suppressed with a MMP inhibitor. Arch Ophthalmol 117:498-503